Infliximab in Refractory Uveitis Due to Behcet's Disease: Long Term Follow-up and Therapy Optimization. Multicenter Study of 103 Caucasian Patients

被引：0

作者：

Luis Martin-Varillas, Jose ^{[1
]}

Atienza-Mateo, Belen ^{[2
,3
]}

Calvo-Rio, Vanesa ^{[4
]}

Beltran-Catalan, Emma ^{[5
]}

Adan, Alfredo ^{[6
]}

Hernandez Garfella, Marisa ^{[7
]}

Valls-Pascual, Elia ^{[8
]}

Sellas-Fernandez, Agustin ^{[9
]}

Ortego, N. ^{[10
]}

Fonollosa, Alejandro ^{[11
]}

Maiz Alonso, Olga ^{[12
]}

Torre, Ignacio ^{[13
]}

Fernandez-Espartero, Cruz ^{[14
]}

Jovani, Vega ^{[15
]}

Peiteado, Diana ^{[16
]}

Diaz Valle, David ^{[17
]}

Romero-Yuste, Susana ^{[18
]}

Aurrecoechea, Elena ^{[1
]}

Garcia-Arias, Miriam ^{[19
]}

Angel Caracuel, Miguel ^{[20
]}

Insua, Santos ^{[21
]}

Gonzalez-Suarez, Senen ^{[22
]}

Sanchez Andrade, Amalia ^{[23
]}

Francisco Linares, Luis ^{[24
]}

Garcia Gonzalez, Alfredo J. ^{[25
]}

Almodovar, Raquel ^{[26
]}

Carrasco Cubero, Carmen ^{[27
]}

Alcalde Villar, Maria ^{[28
]}

Fernandez-Carballido, C. ^{[29
]}

Pages, Fred A. ^{[30
]}

Pena Sainz-Pardo, Eva ^{[25
]}

Demetrio-Pablo, Rosalia ^{[4
]}

Castaneda, Santos ^{[31
]}

Angel Gonzalez-Gay, Miguel ^{[32
]}

Luis Hernandez, Jose ^{[4
]}

Blanco, Ricardo ^{[4
]}

机构：

[1] Hosp Sierrallana, Torrelavega, Spain

[2] Hosp Univ Marques Valdecilla, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain

[3] Hosp Univ Marques Valdecilla, Dept Rheumatol, Santander, Spain

[4] Hosp Univ Marques Valdecilla, Santander, Spain

[5] Del Mar Univ Hosp, Barcelona, Spain

[6] Hosp Clin Barcelona, Barcelona, Spain

[7] Hosp Valencia, Valencia, Spain

[8] Hosp Doctor Peset, Valencia, Spain

[9] Hosp Valle De Hebron, Barcelona, Spain

[10] Hosp San Cecilio, Granada, Spain

[11] Hosp De Cruces, Bilbao, Spain

[12] Hosp Univ Donostia, San Sebastian, Pais Vasco, Spain

[13] Hosp Basurto, Bilbao, Spain

[14] Hosp Mostoles, Madrid, Spain

[15] Hosp Alicante, Alicante, Spain

[16] Hosp La Paz IdiPAZ, Madrid, Spain

[17] Hosp Clin San Carlos, Madrid, Spain

[18] Hosp Pontevedra, Coruna, Spain

[19] Hosp La Princesa, Madrid, Spain

[20] Hosp Univ Reina Sofia, Cordoba, Spain

[21] Hosp Santiago De Compostela, Santiago De Compostela, Spain

[22] Hosp Cabuenes, Gijon, Spain

[23] Hosp Lucus Augusti, Lugo, Spain

[24] Hosp Arrixaca, Murcia, Spain

[25] Hosp 12 Octubre, Madrid, Spain

[26] Fdn Alcorcon Univ Hosp, Madrid, Spain

[27] Hosp Merida, Merida, Spain

[28] Hosp Severo Ochoa, Madrid, Spain

[29] Hosp San Juan, Alicante, Spain

[30] Hosp Palencia, Palencia, Spain

[31] Univ Autonoma, Princesa Univ Hosp, Madrid, Spain

[32] Hosp Univ Marques de Valdecilla, Santander, Cantabria, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0406

引用

页数：3

共 50 条

[31] Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease
Abu El-Asrar A.M.
Abboud E.B.
Aldibhi H.
Al-Arfaj A.
International Ophthalmology, 2005, 26 (3) : 83 - 92
[32] Adalimumab for treatment of severe Behcet's uveitis: a retrospective long-term follow-up study
Interlandi, E.
Leccese, P.
Oivieri, I.
Latanza, L.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S58 - S62
[33] Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behcet Disease Treated with Infliximab
Al Rashidi, Sultan
Al Fawaz, Abdullah
Kangave, Dustan
Abu El-Asrar, Ahmed M.
OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (06) : 468 - 474
[34] Long-term follow-up of patients with Neuro-Behcet's disease
Kurtuncu, M.
Gunduz, T.
Aydin, B. N.
Emekli, A. S.
Demir, G. Akman
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 355 - 355
[35] Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behcet's disease
Ueda, Sho
Akahoshi, Mitsuteru
Takeda, Atsunobu
Inoue, Yasushi
Omoto, Aya
Ayano, Masahiro
Kimoto, Yasutaka
Mitoma, Hiroki
Arinobu, Yojiro
Niiro, Hiroaki
Tsukamoto, Hiroshi
Horiuchi, Takahiko
Hikita, Shin-Ichi
Fukuhara, Takako
Ishibashi, Tatsuro
Sonoda, Koh-Hei
Akashi, Koichi
EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (01) : 9 - 15
[36] Long-term outcomes of infliximab in patients with Behcet's disease-associated uveitis
Yamana, Satoshi
Hasegawa, Eiichi
Takeda, Atsunobu
Yawata, Nobuyo
Sonoda, Koh-Hei
INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (03) : 937 - 944
[37] Optimization of Adalimumab on Refractory Uveitis of Behcet's Syndrome. Multicenter Study of 23 Patients
Fernandez-Diaz, Carlos
Blanco, Ricardo
Calvo-Rio, Vanesa
Loricera, Javier
Sanchez-burson, J.
Ortego Centeno, Norberto
Garcia Serrano, Jose L.
Cordero, Miguel
Vazquez, J.
Beltran, Emma
Valls, Elia
Maiz Alonso, O.
Blanco, Ana
Torre, Ignacio
Garcia-Aparicio, Angel
Toyos-saenz, F. J.
Martinez-Costa, L.
Dominguez-Casas, Lucia C.
Palmou, Natalia
Angel Gonzalez-Gay, Miguel
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[38] Topic infliximab injection for refractory rectal stenosis in Crohn's disease: long-term follow-up in two patients
Teich, Niels
Wallstabe, Ingo
Schiefke, Ingolf
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (09) : 1289 - 1294
[39] Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients
Niels Teich
Ingo Wallstabe
Ingolf Schiefke
International Journal of Colorectal Disease, 2017, 32 : 1289 - 1294
[40] Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide
Gurcan, Mert
Esatoglu, Sinem Nihal
Hamuryudan, Vedat
Saygin, Didem
Ugurlu, Serdal
Seyahi, Emire
Melikoglu, Melike
Fresko, Izzet
Yurdakul, Sebahattin
Yazici, Hasan
Hatemi, Gulen
RHEUMATOLOGY, 2020, 59 (09) : 2264 - 2271

← 1 2 3 4 5 →